UBI is still a viable and effective treatment option for many diverse medical conditions. This device is safe, non-toxic, easy to apply, and uses no drugs. UVBI is expected to have a profound impact on treatment of primarily untreatable illnesses, and to lower the cost of doing so. Interest in the device and sales of the device have been extensive since FFBI published articles in the Townshend Letter for Doctors and the Temple University publication Frontier Perspectives earlier this year. This produces a rapid detoxifying effect with subsidence of toxic symptoms.
Venous oxygen is increased in patients with depressed blood oxygen values.
Of special interest is that a rapid rise in resistance to viral and bacterial infection, acute or chronic, occurs. No harmful effects have been observed with UBI therapy in thousands of cases of viral infections, hepatitis, bacterial infections, hypoxemia, and many other illnesses, particularly blood-related infections. Three to five treatments are typical to inactivate most viruses. There is no risk, hazard or pain to the patient, and no drugs are used. Costs for this treatment are low and should result in considerable savings for the patient as well as for health insurance providers.